2026 Q1 Portfolio Activity
In 2026 Q1, SymBiosis Capital Partners, LLC maintained a portfolio of 12 distinct positions. The most significant new addition was Wave Life Sciences Ltd., now representing 10.30% of the total fund value. Conversely, SymBiosis Capital Partners, LLC completely exited their position in Verastem Inc.
Position History
hover any row below to update
Loading…
Total Positions
12
Quarter
2026 Q1
Top Holding
EVMN (55.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-12 of 12
SymBiosis Capital Partners, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EVMN
Evommune, Inc.
|
Healthcare | 55.80% | 20.03% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
1,280,778 | $29,445,086 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
IVA
Inventiva S.A.
|
Healthcare | 24.76% | 11.04% |
#2
3
Prev: #5
|
6.0 |
—
|
-246,000 | -9.5% |
P
S
|
2,354,000 | $13,064,700 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
WVE
Wave Life Scien...
|
Healthcare | 10.30% | — |
#3
Prev: #—
|
8.5 |
—
|
750,000 | — |
NEW
|
750,000 | $5,437,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
RANI
Rani Therapeuti...
|
Healthcare | 5.11% | 7.77% |
#4
3
Prev: #7
|
2.5 |
—
|
-2,632,415 | -41.8% |
P
S
|
3,667,585 | $2,694,941 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
CLNN
Clene Nanomedic...
|
Consumer Defensive | 4.03% | 4.13% |
#5
4
Prev: #9
|
2.1 |
—
|
-339,401 | -44.0% |
P
S
|
431,094 | $2,125,293 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
SRZNW
Surrozen, Inc.
|
Unknown | 0.00% | 0.00% |
#6
5
Prev: #11
|
1.0 |
—
|
no change | no change |
P
S
|
150,000 | $2,400 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
N/A
Generation Bio ...
|
|
Unknown | 0.00% | 3.45% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-665,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-03-31 | 2026-05-12 | ||
|
AARD
Aardvark Therap...
|
Healthcare | 0.00% | 5.71% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-476,595 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
NUVB
Nuvation Bio In...
|
Healthcare | 0.00% | 10.23% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-1,250,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
PGEN
Precigen Inc
|
Healthcare | 0.00% | 11.45% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-3,000,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
AMPG
Aldeyra Therape...
|
Technology | 0.00% | 12.09% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-2,555,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
VSTM
Verastem Inc
|
Healthcare | 0.00% | 14.10% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-2,000,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 |
Showing 1-12 of 12 holdings